Author

R. H. Larsen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Preaudet· 1 shared A. W. Burgess· 1 shared B. Lee· 1 shared C. U. Rank· 1 shared F. Hollande· 1 shared H. Gao· 1 shared J. Yousef· 1 shared K. Schmiegelow· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Preaudet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TGF-beta1 induced S100 family protein expression is associated with epithelial to mesenchymal transition states and poor survival in pancreatic cancer

R. R. J. Low, K. Y. Fung, H. Gao, A. Preaudet, L. F. Dagley, J. Yousef, B. Lee, R. H. Larsen, N. J. Kershaw, A. W. Burgess, P. Gibbs, F. Hollande, M. D. W. Griffin, S. M. Grimmond, T. L. Putoczki

The paper links TGF-beta1-induced S100 family protein expression to EMT states and poor survival in pancreatic cancer using a murine organoid biobank.

bioRxiv · Feb 25, 2022 · PreprintCancer Biology

Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: a systematic review

L. N. Toksvang, K. Schmiegelow, M. S. Schmidt, S. Arup, R. H. Larsen, T. L. Frandsen, C. U. Rank

This review assesses hepatotoxicity risks of 6-thioguanine treatment in ALL and IBD patients, finding that lower doses (≤12 mg/m2/day) are associated with minimal hepatotoxicity.

bioRxiv · Jan 31, 2019Pharmacology & Toxicology